NCT06668142 is a NA clinical trial of Beacon Platform in Benign Prostatic Hyperplasia, sponsored by Andromeda Surgical.

Who is sponsoring NCT06668142?

NCT06668142 is sponsored by Andromeda Surgical.

What drugs are being tested in NCT06668142?

Interventions in NCT06668142: Beacon Platform.

What condition does NCT06668142 study?

NCT06668142 studies Benign Prostatic Hyperplasia.

Is NCT06668142 still recruiting?

NCT06668142 is currently recruiting now. Last updated 23 March 2026.

Last reviewed 2026-03-23 · How we verify

NCT06668142

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Prospective, Multicenter, Open-label Study of the Beacon Platform for Holmium Laser Enucleation of the Prostate (HoLEP)

Recruiting now NA Last updated 23 March 2026

What this trial tests

NA trial testing Beacon Platform in Benign Prostatic Hyperplasia in 54 participants. Currently enrolling.

Timeline

12 December 2024

Primary endpoint
30 December 2026

30 December 2026

Quick facts

Lead sponsor	Andromeda Surgical
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	54
Start date	12 December 2024
Primary completion	30 December 2026
Estimated completion	30 December 2026
Sites	3 locations across Chile, New Zealand

Drugs / interventions tested

Beacon Platform

Conditions studied

Benign Prostatic Hyperplasia — all drugs for Benign Prostatic Hyperplasia →

Sponsor

Andromeda Surgical — full company profile →

Who can join

45 and older, male only, with Benign Prostatic Hyperplasia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Robotic assisted surgery for benign prostatic hyperplasia (BPH)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Benign Prostatic Hyperplasia

Currently open trials in the same condition.

NCT07444385 — A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Subjects · Phase 1 · recruiting
NCT07293442 — Pelvic Floor Muscle Exercise for Lower Urinary Tract Symptoms After Surgery for Benign Prostatic Hyperplasia. · NA · recruiting
NCT06657872 — Local Anesthesia With Schelin Catheter in Rezum Treatment: a Randomized Controlled Trial · NA · recruiting
NCT06852859 — Patient-reported Pain and Symptom Relief During Three Months After Surgery for Benign Prostatic Hyperplasia · recruiting
NCT06849258 — A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06668142 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Andromeda Surgical
Last refreshed: 23 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06668142.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing